Lv7
4450 积分 2021-03-17 加入
Positioning oral selective estrogen receptor degraders in patients with metastatic breast cancer
7天前
已完结
Selective Estrogen Receptor Modulators (SERMs): Advances, Challenges, and Future Prospects in ER+ Breast Cancer Therapy
8天前
已完结
Navigating first- and second-line treatment options in HR+HER2-negative advanced breast cancer
8天前
已完结
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial
23天前
已完结
Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors
1个月前
已关闭
Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II Trial
1个月前
已完结
Nucleic Acid–Based Therapies — The Next Frontier in Treating Dyslipidemias
2个月前
已关闭
siRNAs targeting ANGPTL3 for mixed dyslipidemia
2个月前
已完结
Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent
2个月前
已完结
Does siRNA therapy against ANGPTL3 bring new hope in homozygous familial hypercholesterolaemia?
2个月前
已关闭
皖公网安备34019202002308
